ProfileGDS4132 / 208715_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 93% 92% 92% 94% 92% 92% 93% 89% 93% 93% 94% 92% 93% 93% 95% 93% 92% 91% 93% 93% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101503.27593
GSM201543Muscle PCOS pioglitazone 121457.70292
GSM201544Muscle PCOS pioglitazone 161549.79992
GSM201545Muscle PCOS pioglitazone 201657.46494
GSM201829Muscle PCOS pioglitazone 231536.28192
GSM201830Muscle PCOS pioglitazon 251486.76692
GSM201831Muscle PCOS pioglitazone 271555.87493
GSM201832Muscle PCOS pioglitazone 31395.1389
GSM201833Muscle PCOS pioglitazone 41584.37893
GSM201834Muscle PCOS pioglitazone 81588.55993
GSM201835Muscle PCOS after pioglitazone 102677.2494
GSM201836Muscle PCOS after pioglitazone 122561.05292
GSM201837Muscle PCOS after pioglitazone 162599.41493
GSM201838Muscle PCOS after pioglitazone 202664.60293
GSM201839Muscle PCOS after pioglitazone 232733.71495
GSM201840Muscle PCOS after pioglitazone 252596.7693
GSM201841Muscle PCOS after pioglitazone 272518.87692
GSM201842Muscle PCOS after pioglitazone 32470.47191
GSM201843Muscle PCOS after pioglitazone 42573.30993
GSM201844Muscle PCOS after pioglitazone 82583.15493